国际标准期刊号: 2155-952X

生物技术与生物材料

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 研究圣经
  • 中国知网(CNKI)
  • 访问全球在线农业研究 (AGORA)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Advancements in Cardiovascular Biomaterials: Pioneering the Future ofCardiac Care

Wei Wang

Cardiovascular disease remains a global health challenge, necessitating continuous innovation in medical technology and treatment modalities. This abstract explores the remarkable progress in cardiovascular biomaterials, a burgeoning field that is reshaping the landscape of cardiac care. These biomaterials, engineered to interact with the cardiovascular system, are driving breakthroughs in the prevention, diagnosis, and treatment of cardiovascular disorders. This abstract also highlights the vital role of nanotechnology in cardiovascular biomaterials, enabling precise drug delivery systems, imaging contrast agents, and the development of nanocomposites with exceptional mechanical properties. These innovations are facilitating minimally invasive procedures and personalized treatment regimens tailored to each patient's unique cardiovascular profile. The ongoing advancements in cardiovascular biomaterials represent a paradigm shift in the field of cardiac care. These materials hold immense promise for enhancing patient outcomes, reducing healthcare costs, and ultimately, improving the quality of life for individuals affected by cardiovascular disease. As research and development in this field continue to flourish, the future of cardiac care appears brighter than ever, promising innovative solutions to combat the world's leading cause of mortality.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。